Publications by authors named "Fadia T Shaya"

100Publications

Association of Criminal Statutes for Opioid Use Disorder With Prevalence and Treatment Among Pregnant Women With Commercial Insurance in the United States.

JAMA Netw Open 2019 03 1;2(3):e190338. Epub 2019 Mar 1.

Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamanetworkopen.2019.0338DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484651PMC
March 2019

Consumer Health Information Technology in the Prevention of Substance Abuse: Scoping Review.

J Med Internet Res 2019 01 30;21(1):e11297. Epub 2019 Jan 30.

Icahn School of Medicine at Mount Sinai, New York, NY, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2196/11297DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372939PMC
January 2019

Cardiovascular Events Following Treatment Initiation with Atypical Antipsychotic Medications in Publicly Insured U.S. Youth.

J Child Adolesc Psychopharmacol 2018 09 5;28(7):445-453. Epub 2018 Jul 5.

4 Department of Epidemiology and Public Health, University of Maryland , Baltimore, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/cap.2017.0121DOI Listing
September 2018

Factors associated with use of disease modifying agents for rheumatoid arthritis in the National Hospital and Ambulatory Medical Care Survey.

Semin Arthritis Rheum 2018 04 18;47(5):649-653. Epub 2017 Oct 18.

Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, 220 Arch Street, 12th Floor, Baltimore, MD 21201.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2017.10.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866186PMC
April 2018

Tree-based Claims Algorithm for Measuring Pretreatment Quality of Care in Medicare Disabled Hepatitis C Patients.

Med Care 2017 12;55(12):e104-e112

*University of Maryland School of Pharmacy †University of Maryland School of Medicine, Baltimore, MD ‡Howard University College of Medicine, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MLR.0000000000000405DOI Listing
December 2017

Predicting Factors of Depression, Antidepressant Use and Positive Response to Antidepressants in Perinatal and Postpartum Women.

Clin Pract Epidemiol Ment Health 2017 30;13:49-60. Epub 2017 Jun 30.

University of Maryland School of Pharmacy, Department of Pharmaceutical Health Services Research Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1745017901713010049DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510557PMC
June 2017

Evaluation of PCMH Model Adoption on Teamwork and Impact on Patient Access and Safety.

J Prim Care Community Health 2017 Apr 12;8(2):77-82. Epub 2016 Nov 12.

4 Maryland Health Care Commission, DHMH Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2150131916678496DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932663PMC
April 2017

Health economics of insomnia treatments: The return on investment for a good night's sleep.

Sleep Med Rev 2016 12 28;30:72-82. Epub 2015 Nov 28.

Department of Medicine, Division of Pulmonary and Critical Care, University of Maryland School of Pharmacy, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.smrv.2015.11.004DOI Listing
December 2016

Impact of Case Mix Severity on Quality Improvement in a Patient-centered Medical Home (PCMH) in the Maryland Multi-Payor Program.

J Am Board Fam Med 2016 Jan-Feb;29(1):116-25

From the Department of Family and Community Medicine, University of Maryland School of Medicine, Baltimore (NK); the Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore (FTS, VVC); the Center for Health Information Technology and Innovative Care Delivery, Department of Health and Mental Hygiene, Baltimore, MD (DS); and the Maryland Health Care Commission, Department of Health and Mental Hygiene, Baltimore (BS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3122/jabfm.2016.01.150067DOI Listing
December 2016

Determinants of quality of care and treatment initiation in Medicare disabled patients with chronic hepatitis C.

Expert Rev Gastroenterol Hepatol 2015 2;9(11):1447-62. Epub 2015 Nov 2.

c 3 Department of Medicine, Howard University College of Medicine, 2041 Georgia Ave. Suite 5C02, Washington, DC 20060, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474124.2015.1095087DOI Listing
August 2016

Impact of a comprehensive pharmacist medication-therapy management service.

J Med Econ 2015 9;18(10):828-37. Epub 2015 Jun 9.

c c Sanofi U.S., Inc. Bridgewater , NJ , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3111/13696998.2015.1052463DOI Listing
July 2016

Disease-modifying therapy and hospitalization risk in heart failure patients.

Am J Manag Care 2015 Jan;21(1):39-47

Heart and Vascular Center, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115. E-mail:

View Article

Download full-text PDF

Source
January 2015

Contextual analysis of determinants of late diagnosis of hepatitis C virus infection in medicare patients.

Hepatology 2015 Jul 8;62(1):68-78. Epub 2015 Apr 8.

Howard University College of Medicine, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.27775DOI Listing
July 2015

Incident depression increases medical utilization in Medicaid patients with hypertension.

Expert Rev Cardiovasc Ther 2015 Jan 9;13(1):111-8. Epub 2014 Dec 9.

Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, 220 Arch St, 12th Floor, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14779072.2014.969712DOI Listing
January 2015

Development of heart failure in Medicaid patients with type 2 diabetes treated with pioglitazone, rosiglitazone, or metformin.

J Manag Care Spec Pharm 2014 Sep;20(9):895-903

University of Maryland School of Pharmacy, 220 Arch St., 12th Fl., Rm. 01-204, Baltimore, MD 21201.

View Article

Download full-text PDF

Source
http://www.jmcp.org/doi/10.18553/jmcp.2014.20.9.895
Publisher Site
http://dx.doi.org/10.18553/jmcp.2014.20.9.895DOI Listing
September 2014

Association between mental health and comorbid obesity and hypertension among children and adolescents in the US.

Eur Child Adolesc Psychiatry 2015 May 22;24(5):497-502. Epub 2014 Aug 22.

Pharmaceutical Health Services Research Department, School of Pharmacy, University of Maryland, 220 Arch St., 12th Floor, Baltimore, MD, 21201, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00787-014-0598-8DOI Listing
May 2015

Association between interferon use and reduced metabolic and vascular complications among patients with hepatitis C.

Expert Rev Gastroenterol Hepatol 2014 Nov 9;8(8):973-83. Epub 2014 Aug 9.

University of Maryland School of Pharmacy, 220 Arch Street, Saratoga Offices 12th Floor, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474124.2014.945911DOI Listing
November 2014

Cardiovascular event-free survival after adjuvant radiation therapy in breast cancer patients stratified by cardiovascular risk.

Cancer Med 2014 Oct 10;3(5):1342-52. Epub 2014 Jul 10.

Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.283DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302684PMC
October 2014

Clinical value of tapentadol extended-release in painful diabetic peripheral neuropathy.

Expert Rev Clin Pharmacol 2014 Mar;7(2):203-9

University of Maryland School of Pharmacy, 300 West Lombard St, Apt 413, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17512433.2014.889562DOI Listing
March 2014

Effect of social networks intervention in type 2 diabetes: a partial randomised study.

J Epidemiol Community Health 2014 Apr 2;68(4):326-32. Epub 2013 Dec 2.

University of Maryland School of Pharmacy, , Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jech-2013-203274DOI Listing
April 2014

Comparative and cost effectiveness of treatment modalities for hepatocellular carcinoma in SEER-Medicare.

Pharmacoeconomics 2014 Jan;32(1):63-74

Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, 220 Arch Street, 12th floor, Baltimore, MD, 21201, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40273-013-0109-7DOI Listing
January 2014

Multispecialist Care and Mortality in Hepatocellular Carcinoma.

Am J Clin Oncol 2015 Dec;38(6):557-63

*Department of Pharmaceutical Health Services Research †Division of Surgical Oncology, University of Maryland School of Medicine, Baltimore, MD ‡Department of Health Economics and Outcomes Research, Bayer HealthCare Pharmaceuticals Inc., Wayne, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000000DOI Listing
December 2015

Transarterial chemoembolization treatment: association between multiple treatments, cumulative expenditures, and survival.

Value Health 2013 Jul-Aug;16(5):760-8. Epub 2013 May 28.

Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2013.03.1630DOI Listing
November 2013

Increased prevalence of obstructive lung disease in patients with obstructive sleep apnea.

Sleep Breath 2014 Mar 4;18(1):69-75. Epub 2013 Jun 4.

Sleep-Wake Disorders Unit, Soroka University Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11325-013-0850-3DOI Listing
March 2014

Comparison of physician practice patterns for older adults compared to NHANES diabetes cohort on oral/other therapy.

Expert Rev Pharmacoecon Outcomes Res 2013 Feb;13(1):153-60

University of Maryland School of Pharmacy, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/erp.12.75DOI Listing
February 2013

Social networks help control hypertension.

J Clin Hypertens (Greenwich) 2013 Jan 26;15(1):34-40. Epub 2012 Nov 26.

Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jch.12036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580229PMC
January 2013

Delivering cost-effective care for COPD in the USA: recent progress and current challenges.

Expert Rev Pharmacoecon Outcomes Res 2012 Dec;12(6):725-31

Pharmaceutical Health Services Research, University of Maryland, School of Pharmacy, 220 Arch Street, 12th floor, Room 01-209, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/erp.12.69DOI Listing
December 2012

A qualitative evaluation of a citywide Community Health Partnership program.

J Natl Med Assoc 2012 Jan-Feb;104(1-2):53-60

University of Maryland School of Pharmacy, Department of Pharmaceutical Health Services Research, Saratoga Building, 12th Floor, 220 Arch St, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0027-9684(15)30124-3DOI Listing
July 2012

Diabetes knowledge in a high risk urban population.

Ethn Dis 2011 ;21(4):485-9

Center on Drugs and Public Policy, University of Maryland School of Pharmacy, 515 West Lombard Street, 2nd Floor, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
April 2012

The use of age-period-cohort analysis to determine the impact of economic development on COPD mortality in Hong Kong.

Expert Rev Pharmacoecon Outcomes Res 2012 Feb;12(1):19-21

University of Maryland School of Pharmacy and School of Medicine, 220 Arch Street, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/erp.11.101DOI Listing
February 2012

Decision support tools to optimize economic outcomes for type 2 diabetes.

Am J Manag Care 2011 Nov;17 Suppl 14:S377-83

University of Maryland School of Pharmacy, 220 Arch St, 12th Floor, Room 01-204, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
November 2011

Readmissions after unauthorized discharges in the cardiovascular setting.

Med Care 2011 Feb;49(2):215-24

Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00005650-201102000-000
Publisher Site
http://dx.doi.org/10.1097/MLR.0b013e31820192a5DOI Listing
February 2011

Social networks in cardiovascular disease management.

Expert Rev Pharmacoecon Outcomes Res 2010 Dec;10(6):701-5

University of Maryland School of Pharmacy, 220 Arch Street, 12th Floor Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/erp.10.68DOI Listing
December 2010

US trends in glycemic control, treatment, and comorbidity burden in patients with diabetes.

J Clin Hypertens (Greenwich) 2010 Oct;12(10):826-32

University of Maryland, School of Pharmacy, Pharmaceutical Health Services Research, 220 Arch Street, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1751-7176.2010.00365.xDOI Listing
October 2010

Quantifying the role of natalizumab in health and economic outcomes in multiple sclerosis.

Am J Manag Care 2010 Jun;16(6 Suppl):S171-7

Hope Neurology, Knoxville, TN, USA.

View Article

Download full-text PDF

Source
June 2010

Clinical evaluation of natalizumab for formulary consideration.

Expert Opin Biol Ther 2010 Aug;10(8):1279-87

University of Maryland School of Pharmacy, Center on Drugs and Public Policy, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2010.505234DOI Listing
August 2010

Depression following thrombotic cardiovascular events in elderly medicare beneficiaries: risk of morbidity and mortality.

Cardiol Res Pract 2009 22;2009:194528. Epub 2009 Dec 22.

Division of Clinical and Outcomes Research, Lovelace Respiratory Research Institute, Albuquerque, NM 87108, USA.

View Article

Download full-text PDF

Source
http://www.hindawi.com/journals/crp/2009/194528/
Publisher Site
http://dx.doi.org/10.4061/2009/194528DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2800999PMC
July 2011

The cost effectiveness and budget impact of natalizumab for formulary inclusion.

J Med Econ 2010 Mar;13(1):63-9

University of Maryland School of Pharmacy, 220 Arch Street, Baltimore, MD 21201, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3111/13696990903543424DOI Listing
March 2010

Economic implications of comorbid conditions among Medicaid beneficiaries with COPD.

Respir Med 2010 May 2;104(5):697-704. Epub 2009 Dec 2.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA 02111, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09546111090037
Publisher Site
http://dx.doi.org/10.1016/j.rmed.2009.11.009DOI Listing
May 2010

Effect of Persistence with Drug Therapy On the Risk of Myocardial Re-infarction.

P T 2008 May;33(5):288-95

Dr. Shaya is Associate Professor in the Department of Pharmaceutical Health Services Research at the University of Maryland's School of Pharmacy in Baltimore, Maryland. At the time of this writing, Dr. Gu was a Graduate Research Assistant and doctoral student at the university. She is currently an Associate Consultant for Analysis Group, Inc., in Boston, Massachusetts. Ms. Yan is a doctoral student in the Department of Pharmaceutical Health Services Research at the University of Maryland.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683601PMC
May 2008

Ethnic disparities, hospital quality, and discharges against medical advice among patients with cardiovascular disease.

Ethn Dis 2009 ;19(2):172-8

Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
July 2009

Elevated economic burden in obstructive lung disease patients with concomitant sleep apnea syndrome.

Sleep Breath 2009 Nov 30;13(4):317-23. Epub 2009 May 30.

Department of Pharmaceutical Health Services Research, University of Maryland, Baltimore, MD, 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11325-009-0266-2DOI Listing
November 2009

Predictors of compliance with antihypertensive therapy in a high-risk medicaid population.

J Natl Med Assoc 2009 Jan;101(1):34-9

Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, 220 Arch St, 12th Floor, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0027-9684(15)30808-7DOI Listing
January 2009

Effect of medication burden on persistent use of lipid-lowering drugs among patients with hypertension.

Am J Manag Care 2008 Nov;14(11):710-6

School of Pharmacy, University of Maryland, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
November 2008

Predictors of fixed-dose combination antihypertensive drug therapy in a Medicaid population.

J Am Soc Hypertens 2008 Nov-Dec;2(6):469-75. Epub 2008 Jul 14.

Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jash.2008.04.011DOI Listing
October 2012

Prescribing trends and drug budget impact of the ARBs in the UK.

Value Health 2009 Mar-Apr;12(2):302-8. Epub 2008 Jul 18.

EPIC, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1524-4733.2008.00423.xDOI Listing
September 2010

The burden of obstructive lung disease in Medicaid and managed care populations.

Authors:
Fadia T Shaya

Manag Care 2005 Jul;14(7 Suppl Obstructie Lung):20-3; discussion 24-6

University of Maryland School of Pharmacy, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
July 2005

Burden of concomitant asthma and COPD in a Medicaid population.

Chest 2008 Jul 13;134(1):14-9. Epub 2008 Mar 13.

Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, 220 Arch St, Twelfth Floor, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.07-2317DOI Listing
July 2008

School-based obesity interventions: a literature review.

J Sch Health 2008 Apr;78(4):189-96

Center on Drugs and Public Policy, Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1746-1561.2008.00285.xDOI Listing
April 2008

Metabolic Syndrome Prevalence in an Urban African American Population.

Diabetes Metab Syndr 2007 Sep;1(3):151-157

Division of Hypertension, University of Maryland Medical System, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dsx.2007.05.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303200PMC
September 2007

Diabetic retinopathy.

Clin Ophthalmol 2007 Sep;1(3):259-65

Center on Drugs and Public Policy, University of Maryland School of Pharmacy, Pharmaceutical Health Services Research, 220 Arch Street, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701130PMC
September 2007

Utilizing new prescription drugs: disparities among non-Hispanic whites, non-Hispanic blacks, and Hispanic whites.

Health Serv Res 2007 Aug;42(4):1499-519

Division of Health Science Administration, Department of Pharmaceutical Sciences, University of Tennessee College of Pharmacy, 847 Monroe Ave., Room 205R, Memphis, TN 38163, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1475-6773.2006.00682.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1955281PMC
August 2007

New diagnosis of hypertension among celecoxib and nonselective NSAID users: a population-based cohort study.

Ann Pharmacother 2007 Jun 8;41(6):937-43. Epub 2007 May 8.

Pharmaceutical Health Services Research Department, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1345/aph.1H659
Publisher Site
http://dx.doi.org/10.1345/aph.1H659DOI Listing
June 2007

Health-related quality of life as a potential predictor in chronic obstructive lung disease patients.

Expert Rev Pharmacoecon Outcomes Res 2007 Apr;7(2):129-35

Associate Professor and Associate Director, University of Maryland, Center on Drugs & Public Policy, School of Pharmacy, 220 Arch Street, Room 01-204, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.7.2.129DOI Listing
April 2007

The case for cultural competence in health professions education.

Am J Pharm Educ 2006 Dec;70(6):124

Center on Drugs and Public Policy, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1803701PMC
http://dx.doi.org/10.5688/aj7006124DOI Listing
December 2006

Bridging the gap between pharmacoeconomics and the real-world practice of managed care pharmacy.

J Manag Care Pharm 2007 Jan-Feb;13(1):66-7

University of Maryland School of Pharmacy, 220 Arch St., 12th Fl., Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://www.jmcp.org/doi/10.18553/jmcp.2007.13.1.66
Publisher Site
http://dx.doi.org/10.18553/jmcp.2007.13.1.66DOI Listing
June 2007

A perspective on African American participation in clinical trials.

Contemp Clin Trials 2007 Feb 7;28(2):213-7. Epub 2006 Oct 7.

Center on Drugs and Public Policy, University of Maryland School of Pharmacy, Pharmaceutical Health Services Research, 220 Arch Street, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cct.2006.10.001DOI Listing
February 2007

Drug therapy persistence and stroke recurrence.

Am J Manag Care 2006 Jun;12(6):313-9

Department of Epidemiology and Preventive Medicine, University of Maryland, 515 West Lombard St, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
June 2006

New treatment approaches to diabetes.

Manag Care 2006 May;15(5):38, 40-1

University of Maryland School of Pharmacy, Center on Drugs and Public Policy, 515 W Lombard St #256, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
May 2006

Comparison of first refill rates among users of sertraline, paroxetine, and citalopram.

Clin Ther 2006 Feb;28(2):297-305; discussion 296

Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinthera.2006.02.006DOI Listing
February 2006

Addressing cardiovascular disparities through community interventions.

Ethn Dis 2006 ;16(1):138-44

Center on Drugs and Public Policy, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
June 2006

Adjusting for risk and confounding in outcomes research.

Expert Rev Pharmacoecon Outcomes Res 2006 Apr;6(2):109-10

Assistant Professor, Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, 515 West Lombard Street Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/14737167.6.2.109
Publisher Site
http://dx.doi.org/10.1586/14737167.6.2.109DOI Listing
April 2006

Effect of initial ziprasidone dose on treatment persistence in schizophrenia.

Schizophr Res 2006 Apr 20;83(2-3):277-84. Epub 2006 Mar 20.

University of Maryland School of Pharmacy, 515 W. Lombard Street, Room 262, Baltimore, MD 21201, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2006.01.013DOI Listing
April 2006

Deriving effectiveness information for decision-making.

Expert Rev Pharmacoecon Outcomes Res 2006 Feb;6(1):5-7

University of Maryland School of Pharmacy, Center on Drugs and Public Policy, 515 West Lombard Street, #256, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.6.1.5DOI Listing
February 2006

Compliance with medicine.

Authors:
Fadia T Shaya

Ophthalmol Clin North Am 2005 Dec;18(4):611-7

Department of Pharmaceutical Health Services Research, Center on Drugs and Public Policy, University of Maryland School of Pharmacy, 515 West Lombard Street, Room #256, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ohc.2005.07.005DOI Listing
December 2005

Modeling risk of gastrointestinal events among Medicaid NSAID users using propensity scores.

Expert Rev Pharmacoecon Outcomes Res 2005 Oct;5(5):625-32

Center on Drugs & Public Policy, University of Maryland School of Pharmacy, 515 West Lombard Street, 2nd Floor, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.5.5.625DOI Listing
October 2005

Persistence with overactive bladder pharmacotherapy in a Medicaid population.

Am J Manag Care 2005 Jul;11(4 Suppl):S121-9

Center on Drugs and Public Policy, University of Maryland School of Pharmacy, Baltimore, USA.

View Article

Download full-text PDF

Source
July 2005

Assessing potential risks and evaluating expected benefits.

Manag Care Interface 2005 May;18(5):27-30

Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, School of Medicine, Epidemiology and Preventive Medicine, Baltimore 21201, USA.

View Article

Download full-text PDF

Source
May 2005

Review of cost-effectiveness studies of pegylated therapies for hepatitis C.

Expert Rev Pharmacoecon Outcomes Res 2005 Jun;5(3):339-51

University of Maryland School of Pharmacy, 515 West Lombard Street, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.5.3.339DOI Listing
June 2005

Developing benchmarks for adherence studies.

Expert Rev Pharmacoecon Outcomes Res 2005 Jun;5(3):229-32

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.5.3.229DOI Listing
June 2005

Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram.

Pharmacotherapy 2005 May;25(5):660-7

Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1592/phco.25.5.660.63590DOI Listing
May 2005

Medicaid managed care: disparities in the use of thiazolidinediones compared with metformin.

J Natl Med Assoc 2005 Apr;97(4):493-7

Outcomes Research/Epidemiology Center on Drugs and Public Policy University of Maryland School of Pharmacy, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2568710PMC
April 2005

Prescriptions for cyclooxygenase-2 inhibitors and other nonsteroidal anti-inflammatory agents in a medicaid managed care population: African Americans versus Caucasians.

Pain Med 2005 Jan-Feb;6(1):11-7

Center on Drugs and Public Policy, University of Maryland Baltimore-School of Pharmacy, Baltimore, Maryland 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1526-4637.2005.05011.xDOI Listing
May 2005

Selective cyclooxygenase-2 inhibition and cardiovascular effects: an observational study of a Medicaid population.

Arch Intern Med 2005 Jan;165(2):181-6

Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archinte.165.2.181DOI Listing
January 2005

Formulary decision-making considerations: COX-2 inhibitors.

Manag Care Interface 2004 Nov;17(11):29-36, 41

Center on Drugs & Public Policy, University of Maryland School of Pharmacy, Baltimore 21201, USA.

View Article

Download full-text PDF

Source
November 2004

Formulary decision methodology in the context of health system costs and insurance trends.

Expert Rev Pharmacoecon Outcomes Res 2004 Dec;4(6):595-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.4.6.595DOI Listing
December 2004

Cost studies in clinical trials.

Expert Rev Pharmacoecon Outcomes Res 2004 Dec;4(6):591-4

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.4.6.591DOI Listing
December 2004

Prescription drug spending trends for the privately insured in Maryland, 2000-2001.

Health Aff (Millwood) 2004 Sep-Oct;23(5):226-32

Center on Drugs and Public Policy at the University of Maryland School of Pharmacy, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1377/hlthaff.23.5.226DOI Listing
December 2004

Clinical and economic evaluation of gatifloxacin and levofloxacin.

Expert Rev Pharmacoecon Outcomes Res 2004 Aug;4(4):469-77

University of Maryland School of Pharmacy, Center on Drugs and Public Policy, 515 West Lombard Street, 2nd Floor, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.4.4.469DOI Listing
August 2004

Disparities in prevalence rates for lung, colorectal, breast, and prostate cancers in Medicaid.

J Natl Med Assoc 2004 Jun;96(6):809-16

Center on Drugs and Public Policy, University of Maryland School of Pharmacy, 515 W. Lombard St., Second Floor, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2568358PMC
June 2004

Health care cost of analgesic use in hypertensive patients.

Clin Ther 2004 Feb;26(2):285-93

Center on Drugs and Public Policy, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0149-2918(04)90027-6DOI Listing
February 2004

Summary quality scores for pharmacoeconomic studies: balancing validity with need.

Authors:
Fadia T Shaya

J Manag Care Pharm 2003 Jan-Feb;9(1):87-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18553/jmcp.2003.9.1.87DOI Listing
December 2003

Impact of the fourth hurdle on the international pharmaceutical industry.

Expert Rev Pharmacoecon Outcomes Res 2003 Apr;3(2):169-77

Dept. of Pharmacy Practice and Science, 515 W Lombard St., 2nd Floor, Baltimore, Maryland, MD 21201- 1563, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.3.2.169DOI Listing
April 2003

Incidence versus prevalence modeling in pharmacoeconomics.

Expert Rev Pharmacoecon Outcomes Res 2002 Oct;2(5):435-42

Center on Drugs and Public Policy, University of Maryland School of Pharmacy, 100 North Greene Street, 6th floor, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.2.5.435DOI Listing
October 2002